Difference between revisions of "Kralovics R, et al. N. Engl. J. Med. (2005) cited as Ref 314 in DOI: 10.1038/s41392-020-0110-5 (Q9577)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Kralovics R, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: Page(s) (P105): 1779-1790, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
(6 intermediate revisions by the same user not shown) | |||||||||||||||
Property / DOI Identifier | |||||||||||||||
+ | |||||||||||||||
Property / DOI Identifier: 10.1056/NEJMoa051113 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / PubMed ID | |||||||||||||||
+ | |||||||||||||||
Property / PubMed ID: 15858187 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2005
| ||||||||||||||
Property / Publication Date: 2005 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Published In Name String | |||||||||||||||
+ | N. Engl. J. Med. | ||||||||||||||
Property / Published In Name String: N. Engl. J. Med. / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Volume | |||||||||||||||
+ | 352 | ||||||||||||||
Property / Volume: 352 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / title | |||||||||||||||
+ | A gain-of-function mutation of JAK2 in myeloproliferative disorders (English) | ||||||||||||||
Property / title: A gain-of-function mutation of JAK2 in myeloproliferative disorders (English) / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Page(s) | |||||||||||||||
+ | 1779-1790 | ||||||||||||||
Property / Page(s): 1779-1790 / rank | |||||||||||||||
+ | Normal rank |
Latest revision as of 15:37, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Kralovics R, et al. N. Engl. J. Med. (2005) cited as Ref 314 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kralovics R
0 references
2005
0 references
N. Engl. J. Med.
0 references
352
0 references
A gain-of-function mutation of JAK2 in myeloproliferative disorders (English)
0 references
1779-1790
0 references